Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

337
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
337
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

736
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
736
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

562
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
562
Autophagy01:27

Autophagy

4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

6.9K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.9K
Depression: Overview01:18

Depression: Overview

331
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
331

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A wearable biomechanical system for medical evaluation of soft tissue disorders.

Science advances·2026
Same author

Distinct roles of AdipoR1 and AdipoR2 in modulating neuronal firing homeostasis in response to adiponectin and AdipoRon.

Cell communication and signaling : CCS·2026
Same author

Healing cascades and infections in wounds monitored using a wearable sensor of gaseous flux.

bioRxiv : the preprint server for biology·2026
Same author

Negative pressure therapy immediately and reversibly increases cutaneous blood flow in a live porcine skin perfusion model.

Journal of wound care·2026
Same author

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Isolation and characterization of <i>Novosphingobium oxfordense</i> sp. nov. and <i>Novosphingobium mississippiense</i> sp. nov. from soil, with LC-MS/MS and genome-based investigation of their glycosphingolipid production.

Frontiers in microbiology·2026

Video Experimental Relacionado

Updated: Sep 9, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

172

Modulación de la autofagia por los antidepresivos: mecanismos e implicaciones

Yuanzi Zheng1, Yanjun Ma2, Yuhang Pan3

  • 1Department of Psychiatry, Shenzhen University General Hospital, Shenzhen University, Shenzhen, 518055, Guangdong, China.

Neurochemical research
|September 4, 2025
PubMed
Resumen

Los antidepresivos mejoran el reciclaje celular (autofagia) para combatir la depresión al eliminar las proteínas tóxicas y reducir la inflamación. Esta revisión destaca la modulación de la autofagia como una clave para los tratamientos personalizados de la depresión.

Palabras clave:
AntidepresivoLa autofagiaLa depresiónLa neuroinflamaciónPlasticidad sináptica

Más Videos Relacionados

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.5K
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

17.7K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

172
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.5K
The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
07:13

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

17.7K

Área de la Ciencia:

  • La neurociencia
  • Biología celular
  • Farmacología

Sus antecedentes:

  • La depresión implica más que desequilibrios de los neurotransmisores; el reciclaje celular (autofagia) es crucial.
  • El papel de la autofagia en la patogénesis y el tratamiento de la depresión es cada vez más reconocido.
  • Los mecanismos de los antidepresivos actuales están siendo reevaluados a través de la lente de la autofagia.

Objetivo del estudio:

  • Revisar cómo los antidepresivos modulan las vías de autofagia para la eficacia terapéutica.
  • Identificar objetivos específicos de autofagia para nuevos tratamientos para la depresión.
  • Discutir los desafíos y oportunidades en la traducción de la investigación de la autofagia a la práctica clínica.

Principales métodos:

  • Revisión completa de la literatura que integra los estudios sobre los antidepresivos y la autofagia.
  • Análisis de la evidencia que vincula la acción antidepresiva con el flujo autofágico, la neuroinflamación y la función mitocondrial.
  • Identificación de objetivos clave relacionados con la autofagia (por ejemplo, ULK1/Beclin-1, TFEB).

Principales resultados:

  • Los antidepresivos (ISRS, SNRIs, TCAs) aumentan el flujo autofágico, ayudando a la neuroprotección.
  • La modulación de la autofagia por los antidepresivos ayuda a eliminar los agregados tóxicos y a reducir la neuroinflamación.
  • La evidencia sugiere que la función mitocondrial mejorada a través de la autofagia contribuye a los efectos antidepresivos.

Conclusiones:

  • La modulación dirigida de la autofagia ofrece una vía prometedora para desarrollar terapias personalizadas de la depresión.
  • La comprensión de los biomarcadores de la autofagia específicos de tipo celular y clínicamente relevantes es esencial para la psiquiatría de precisión.
  • Las estrategias de tratamiento individualizadas basadas en perfiles de autofagia podrían revolucionar el manejo de la depresión.